ARCHIVES

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

Results of NSABP Studies Unchanged When Falsified Data is Excluded: Fisher

May 27, 1994

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000